Process for production of insulin-like growth factor i
CA 1297813 C · Owner: Ono, Hiroki · Inventors: Saito, Yoshimasa; Sato, Susumu; Ueda, Ikuo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Human insulin-like growth factor I (IGF-I) is produced by culturing an organism containing therein a plasmid which includes a synthetic IGF-I gene and a promoter gene upstream of and adjacent to the IGF-I gene to control expression of IGF-I gene, in which the synthetic IGF-I gene codes for the expression of IGF-I, wherein IGF-I consists 70 amino acids in the following sequence: and the promoter gene has no structural gene and recovering, IGF-I as a non fused peptide from the culture broth; IGF-I has insulin-like potency and stimulation potency of sulfateuptake by cartilage.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 24, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 24, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.